Phase II Study to Evaluate the Cardiac Safety of 2 Doses of CHF5993 Both Combined With CHF1535 BID Versus CHF1535 BID in Patients With Moderate to Severe COPD

Clinical trial NCT01584505 · COMPLETED

Trial details

NCT number: NCT01584505
Sponsor: Chiesi Farmaceutici S.p.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2012-04-01
Primary completion: 2012-09-01
Enrollment: 191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.